ISPE announced the results of its 2016 – 2017 International Board of Directors election, revealing a slate of strategic leaders who represent a variety of pharmaceutical industry sectors. The Board is responsible for the governance and strategic direction of the Society and will assume their elected positions at the 2016 ISPE Annual Meeting & Expo, 18 – 21 September in Atlanta, Georgia USA.
“I am looking forward to collaborating with the incoming International Board of Directors to further the organization and advance the Society mission and vision,” said John Bournas, President and CEO, ISPE. “The new leadership team will not only provide invaluable guidance with regards to our strategic direction and efforts to support the biopharmaceutical manufacturing industry, but will continue the organization’s further globalization.”
The following pharmaceutical industry leaders have been elected to positions on the 2016 – 2017 ISPE International Board of Directors:
The following individual served in 2014 – 2016 and has been re-elected to a second two-year term:
In addition to those named above, the following Directors were elected in 2015 to serve a two-year term and will continue their service on the Board:
The 2015 – 2016 Board Chair will continue service on the Board in 2016 – 2017 as Immediate Past Chair:
Immediate Past Chair: Joseph Famulare, Vice President - Global Quality Compliance and
External Collaboration, Genentech/Roche, Pharma Technical Operations
View complete biographical information on all of ISPE’s International Board of Directors.
For more information, contact:
Maria Robertson
Senior Director, Marketing Communications, ISPE
Tel: +1-301-964-9207
Email: mrobertson@ispe.org
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
